Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$31,156,554
+$16,968,377 QoQ
Shares Held
123,814
+89.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#472
of 4,153 holders
Holding Since
Mar 2025
3 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Saudi Central Bank holds $290,663,424 across 9 Drug Manufacturers - General names. ABBV ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
302,628 | $76,858,433 | |
| 2 | LLY |
ELI LILLY & Co
|
56,217 | $67,428,361 | |
| 3 | MRK |
Merck & Co., Inc.
|
440,465 | $56,599,752 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
123,814 | $31,156,554 | |
| 5 | PFE |
Pfizer Inc
|
976,902 | $23,523,800 | |
| 6 | AMGN |
Amgen Inc
|
37,735 | $13,664,598 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
86,886 | $10,977,177 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
142,922 | $8,235,165 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,156,554 | 123,814 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $14,188,177 | 65,236 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $145,616 | 695 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||